Midlife baseline prostate-specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality.
Cirulli GO, Davis M, Stephens A, Chiarelli G, Finati M, Chase M, Tinsley S, Arora S, Sood A, Lughezzani G, Buffi N, Carrieri G, Salonia A, Briganti A, Montorsi F, Rogers C, Abdollah F.
Cirulli GO, et al. Among authors: chase m.
Cancer. 2024 Oct 8. doi: 10.1002/cncr.35563. Online ahead of print.
Cancer. 2024.
PMID: 39377255